Umbilical Cord Blood Banking - Global Market Trajectory & Analytics

Global Umbilical Cord Blood Banking Market to Reach $8.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Umbilical Cord Blood Banking estimated at US$4.2 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2027, growing at a CAGR of 10% over the period 2020-2027. Public Cord Blood Banks, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Private Cord Blood Banks segment is readjusted to a revised 10.3% CAGR for the next 7-year period.





The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 9.4% CAGR

The Umbilical Cord Blood Banking market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 9.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 8.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 42 Featured):

• CBR Systems, Inc.
• China Cord Blood Corporation
• Cord Blood America, Inc.
• CordLife Group Ltd.
• Cryo-Cell International, Inc.
• Cryo-Save AG
• LifeCell International Pvt., Ltd.
• StemCyte Inc.
• ViaCord
• Vita 34 AG